文献速递脑血管病

女性卒中:急性缺血性卒中急性期治疗与早期结局的性别差异

Female Stroke: Sex Differences in Acute Treatment and Early Outcomes of Acute Ischemic Stroke.
PubMed 文献 · Stroke · 2021-01-25

完全校正后,女性静脉溶栓无差异,但更可能接受动脉内治疗;尽管入院残疾更高,女性出院功能结局更好且院内死亡率更低。

要点

  • 完全校正后女性动脉内治疗几率更高,静脉溶栓无性别差异。
  • 女性入院时残疾更重,但出院功能结局更优且院内死亡率更低。
  • 性别差异不能完全由年龄、病前残疾、卒中严重度或病因解释。

核心结论

  • 女性急性缺血性卒中患者接受动脉内治疗的几率更高,不能由临床特征解释。
  • 女性入院残疾更高但院内恢复更有利,表现为死亡率更低和出院功能结局更优。

研究设计与样本

  • 采用 logistic 回归分三步校正协变量,并分2000–2009和2010–2018两个时期建模。

主要发现

  • 完全校正后静脉溶栓无性别差异:2000–2009年 OR 0.99(95%CI 0.94–1.03),2010–2018年 OR 1.0(95%CI 0.98–1.02)。
  • 2010–2018年女性动脉内治疗几率更高:OR 1.12(95%CI 1.08–1.15)。
  • 女性入院残疾更高:2000–2009年 OR 1.10(95%CI 1.07–1.13),2010–2018年 OR 1.09(95%CI 1.07–1.10)。
  • 女性出院功能结局更优:2003–2009年 OR 1.05(95%CI 1.02–1.09),2010–2018年 OR 1.05(95%CI 1.04–1.07)。
  • 女性院内死亡率更低:2000–2009年 OR 0.92(95%CI 0.86–0.97),2010–2018年 OR 0.91(95%CI 0.88–0.93)。

临床怎么用

  • 评估急性缺血性卒中再通治疗时应关注性别差异,女性行动脉内治疗几率更高。
  • 女性入院残疾更重但院内结局更优,预后评估需结合性别与入院状态。

局限性

  • 原文未报告登记研究的具体局限性描述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Men and women are differently affected by acute ischemic stroke (AIS) in many aspects. Prior studies on sex disparities were limited by moderate sample sizes, varying years of data acquisition, and inconsistent inclusions of covariates leading to controversial findings. We aimed to analyze sex differences in AIS severity, treatments, and early outcome and to systematically evaluate the effect of important covariates in a large German stroke registry. METHODS: Analyses were based on the Stroke Registry of Northwestern Germany from 2000 to 2018. We focused on admission-stroke severity and disability, acute recanalization treatment, and early stroke outcomes. Potential sex divergences were investigated via odds ratio (OR) using logistic regression models. Covariates were introduced in 3 steps: (1) base models (age and admission year), (2) partially adjusted models (additionally corrected for acute stroke severity and recanalization treatment), (3) fully adjusted models (additionally adjusted for onset-to-admission time interval, prestroke functional status, comorbidities, and stroke cause). Models were separately fitted for the periods 2000 to 2009 and 2010 to 2018. RESULTS: Data from 761 106 patients with AIS were included. In fully adjusted models, there were no sex differences with respect to treatment with intravenous thrombolysis (2000-2009: OR, 0.99 [95% CI, 0.94-1.03]; 2010-2018: OR, 1.0 [0.98-1.02]), but women were more likely to receive intraarterial therapy (2010-2018: OR, 1.12 [1.08-1.15]). Despite higher disability on admission (2000-2009: OR, 1.10 [1.07-1.13]; 2010-2018: OR, 1.09 [1.07-1.10]), female patients were more likely to be discharged with a favorable functional outcome (2003-2009: OR, 1.05 [1.02-1.09]; 2010-2018: OR, 1.05 [1.04-1.07]) and experienced lower in-hospital mortality (2000-2009: OR, 0.92 [0.86-0.97]; 2010-2018: OR, 0.91 [0.88-0.93]). CONCLUSIONS: Female patients with AIS have a higher chance of receiving intraarterial treatment that cannot be explained by clinical characteristics, such as age, premorbid disability, stroke severity, or cause. Women have a more favorable in-hospital recovery than men because their higher disability upon admission was followed by a lower in-hospital mortality and a higher likelihood of favorable functional outcome at discharge after adjustment for covariates.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Bonkhoff AK, Karch A, Weber R, et al. Female Stroke: Sex Differences in Acute Treatment and Early Outcomes of Acute Ischemic Stroke. Stroke. 2021. PMID: 33493053. doi:10.1161/STROKEAHA.120.032850

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。